<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-91155" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Glycogenic Hepatopathy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kshirsagar</surname>
            <given-names>Ravi K.</given-names>
          </name>
          <aff>Lowell General Hospital / Tufts Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharman</surname>
            <given-names>Tariq</given-names>
          </name>
          <aff>Southern Ohio Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ravi Kshirsagar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Tariq Sharman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>24</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-91155.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Glycogenic hepatopathy (GH) is a rare or possibly under-diagnosed complication seen in children and young adults with poorly controlled type 1 diabetes mellitus and few patients with type 2 diabetes mellitus. It is characterized by a reversible accumulation of excess glycogen in hepatocytes, causing hepatomegaly and transient elevation of liver enzymes, especially transaminases. This activity describes the evaluation and management of glycogenic hepatopathy and highlights the role of the interprofessional team in evaluating and improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of glycogenic hepatopathy.</p></list-item><list-item><p>Review the differential diagnosis of glycogenic hepatopathy.</p></list-item><list-item><p>Summarize the investigations to diagnose glycogenic hepatopathy.</p></list-item><list-item><p>Identify interprofessional team strategies for improving care coordination and outcomes in patients with glycogenic hepatopathy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=91155&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=91155">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-91155.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Glycogenic hepatopathy (GH) is a rare or possibly under-diagnosed complication seen in children and young adults with poorly controlled type 1 diabetes mellitus&#x000a0;and few patients with type 2 diabetes mellitus.<xref ref-type="bibr" rid="article-91155.r1">[1]</xref><xref ref-type="bibr" rid="article-91155.r2">[2]</xref> It is characterized by a reversible accumulation of excess glycogen in hepatocytes, causing hepatomegaly and transient elevation of liver enzymes, especially transaminases. The diagnosis is confirmed by liver biopsy and staining of glycogen using hematoxylin and eosin (HE) stain.</p>
      </sec>
      <sec id="article-91155.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Glycogenic hepatopathy was first described by Pierre Mauriac in 1930 in a pediatric patient with poorly controlled type 1 diabetes (brittle diabetes) who presented with hepatomegaly, cushingoid features, and poor growth, developing a condition known as Mauriac syndrome.<xref ref-type="bibr" rid="article-91155.r3">[3]</xref><xref ref-type="bibr" rid="article-91155.r4">[4]</xref> Since then, many cases have been reported without all the clinical features of Mauriac syndrome. Various terminology was used before glycogenic hepatopathy like hepatic glycogenosis, glycogen storage hepatomegaly, and hepatic glycogen storage disease.<xref ref-type="bibr" rid="article-91155.r5">[5]</xref><xref ref-type="bibr" rid="article-91155.r6">[6]</xref><xref ref-type="bibr" rid="article-91155.r7">[7]</xref><xref ref-type="bibr" rid="article-91155.r8">[8]</xref><xref ref-type="bibr" rid="article-91155.r9">[9]</xref><xref ref-type="bibr" rid="article-91155.r10">[10]</xref> In 2006 Torbenson and colleagues coined the term &#x0201c;glycogenic hepatopathy,&#x0201d; which has been universally adopted.<xref ref-type="bibr" rid="article-91155.r10">[10]</xref></p>
        <p>
<bold>Other Causes of Glycogenic Hepatopathy</bold>
</p>
        <p>Glycogenic hepatopathy has been observed not only in patients with diabetes mellitus but also in patients with dumping syndrome after gastrectomy, anorexia nervosa, high dose corticosteroids, azathioprine use, and high doses of insulin usage.<xref ref-type="bibr" rid="article-91155.r9">[9]</xref><xref ref-type="bibr" rid="article-91155.r11">[11]</xref><xref ref-type="bibr" rid="article-91155.r12">[12]</xref><xref ref-type="bibr" rid="article-91155.r13">[13]</xref></p>
        <p>
<bold>Glycogenic Hepatopathy in Dumping Syndrome</bold>
</p>
        <p>Dumping syndrome is a complication seen in gastric surgeries like gastric bypass surgery where &#x0201c;chyme&#x0201d; rapidly dumps into the small intestine from the stomach without complete absorption. There is a fluctuation between hyperglycemia from feed load and hyperinsulinemia, similar to diabetes mellitus.<xref ref-type="bibr" rid="article-91155.r12">[12]</xref></p>
        <p>
<bold>Anorexia Nervosa</bold>
</p>
        <p>Kransdorf and colleagues reported a case of anorexia nervosa with elevated liver function tests and glycogen deposition.<xref ref-type="bibr" rid="article-91155.r11">[11]</xref>&#x000a0;It is thought that hepatic glycogenosis is the adaptive protective mechanism from potential hypoglycemia in malnutrition.</p>
        <p>&#x000a0;<bold>Short Term Use of High Dose Steroid Therapy</bold></p>
        <p>High-dose steroids elevate glucose levels, gluconeogenesis, and glycogen deposition. Lancu and colleagues&#x000a0;studied 141 patients who had received steroid therapy, 13% had hepatomegaly, and 3 patients had glycogenic hepatopathy.<xref ref-type="bibr" rid="article-91155.r14">[14]</xref>&#x000a0;After discontinuation of steroid therapy, hepatomegaly resolved in all patients. Steroids induce hyperglycemia, causing an increased glycogen production and deposition in the liver, by activation of phosphorylase and subsequent activation of glycogen synthase.</p>
        <p>
<bold>Insulin Overdose</bold>
</p>
        <p>Tsujimoto et al.&#x000a0;reported a case in which a patient with type 2 diabetes mellitus (DM) self-injected a large dose of insulin in an apparent suicide attempt.<xref ref-type="bibr" rid="article-91155.r9">[9]</xref>&#x000a0;He was hypoglycemic and was administered large amounts of intravenous glucose to counteract the persistent hypoglycemia. After the administration of insulin and glucose, he acutely developed acute glycogen storage hepatomegaly. His baseline liver enzymes before the suicide attempt were normal and later increased to 30 fold of the upper normal limits.</p>
      </sec>
      <sec id="article-91155.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>True incidence and prevalence of&#x000a0;glycogenic hepatopathy (GH) are unknown, much of the knowledge is through reported case studies, case series, retrospective cohort study, and more recently case-control study.<xref ref-type="bibr" rid="article-91155.r4">[4]</xref><xref ref-type="bibr" rid="article-91155.r15">[15]</xref>&#x000a0;The prevalence of liver disease among diabetics is estimated to be between 17% to 100%, with non-alcoholic fatty liver disease (NAFLD) and hepatic glycogenosis being the most predominant.<xref ref-type="bibr" rid="article-91155.r16">[16]</xref>&#x000a0;Approximately 98% of GH cases were reported in type 1 DM and the remaining 2% in type 2 DM. 62%&#x000a0;of the reported cases are female patients, and 38% of reported cases are male patients, indicating a slight female predominance, with most cases occurring in adolescence.<xref ref-type="bibr" rid="article-91155.r17">[17]</xref></p>
      </sec>
      <sec id="article-91155.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of glycogenic hepatopathy is incompletely understood. It is believed to be the consequence of recurrent fluctuations in glucose level with hyperglycemia, hypoglycemia, and hyper insulinization. Glycogenic hepatopathy occurs when prolonged or marked hyperglycemia is treated with supraphysiological amounts of insulin.<xref ref-type="bibr" rid="article-91155.r10">[10]</xref>&#x000a0;It has been reported first with hyperglycemia and hypoglycemia with ketoacidosis in type 1 DM. It has also been reported without ketosis or acidosis in patients with type 2 DM and with variable insulin requirements.<xref ref-type="bibr" rid="article-91155.r10">[10]</xref><xref ref-type="bibr" rid="article-91155.r18">[18]</xref>&#x000a0;Glycogen is the polymer of glucose. After feeding, the liver takes up glucose and utilizes it for fuel with the excess to be converted into glycogen. Glycogen is the reservoir for glucose. Glycogenosis and glycogenolysis keep the balance of glycogen levels in the liver. High glucose levels move into the hepatocytes via facilitated diffusion through GLUT 2 transporter, independent of insulin.<xref ref-type="bibr" rid="article-91155.r19">[19]</xref>&#x000a0;The glucose is trapped in the cell after irreversible phosphorylation to glucose-6 phosphate by the enzyme glucokinase. Further, hyperglycemia treated with high doses of insulin polymerizes the glucose 6-phosphate to glycogen by the enzyme glycogen synthase.<xref ref-type="bibr" rid="article-91155.r19">[19]</xref></p>
        <p>The enzyme glycogen synthase exists in two forms, the active form (dephosphorylated) and the inactive form (phosphorylated). The enzyme phosphatase converts the inactive phosphorylated glycogen synthase to the active dephosphorylated form. The phosphatase enzyme is stimulated by high levels of glucose and insulin. Glycogen synthesis continues for some time even after insulin levels have declined while inhibiting glycogenolysis.<xref ref-type="bibr" rid="article-91155.r20">[20]</xref>&#x000a0;With continued glycogen storage, hepatomegaly can develop within a few days to a week and can improve rapidly once the hyperglycemia is controlled.<xref ref-type="bibr" rid="article-91155.r21">[21]</xref></p>
      </sec>
      <sec id="article-91155.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Liver biopsy is the gold standard for diagnosis of glycogenic hepatopathy, typical features are swollen hepatocytes, due to the accumulation of glycogen in the cytoplasm. The hematoxylin and eosin (HE) stain shows pale and enlarged hepatocytes with numerous glycogenated nuclei. Diastase enzyme, when added to the periodic acid-Schiff (PAS) stained specimen, causes enzymatic degradation of glycogen, causing empty hepatocytes (&#x0201c;ghost cells&#x0201d;).<xref ref-type="bibr" rid="article-91155.r22">[22]</xref></p>
      </sec>
      <sec id="article-91155.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with glycogenic hepatopathy can present with asymptomatic elevated liver enzymes or with symptoms of hyperglycemia like polyuria, polydipsia, weight loss, and lethargy. They can also present with diabetic ketoacidosis symptoms like abdominal pain, nausea, and vomiting. Pediatric patients can present with growth failure, delayed puberty, and hepatomegaly. The rapid stretching of the liver capsule due to hepatomegaly can cause abdominal pain. Physical examination reveals hepatomegaly, no other remarkable physical finding is present in patients with glycogenic hepatopathy.</p>
      </sec>
      <sec id="article-91155.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Liver biopsy is crucial for the diagnosis of glycogenic hepatopathy as there is no single serological test to diagnose glycogenic hepatopathy. Based on clinical features, other common causes of chronic hepatitis should be ruled out. Autoimmune serology testing may be done. Glycogen storage diseases result from the congenital absence of various enzymes and usually present in neonates and infants with hepatomegaly and hypoglycemia.<xref ref-type="bibr" rid="article-91155.r13">[13]</xref></p>
        <p>
<bold>Biochemical Features</bold>
</p>
        <p>In more than 90% of the cases, hepatomegaly has been reported, with the varying elevation of transaminases and almost no alkaline phosphatase elevation. The synthetic functions of the liver are preserved. The elevated enzymes are thought to be due to cell membrane injury rather than necrosis.</p>
        <p>
<bold>Imaging</bold>
</p>
        <p>Ultrasound imaging shows hepatomegaly with uniform echogenicity, which can also occur in non-alcoholic fatty liver disease (NAFLD). It cannot differentiate NAFLD from glycogenic hepatopathy.</p>
        <p>The computed tomography&#x000a0;can help in differentiating fatty liver from glycogenic hepatopathy. The fatty liver is hypodense&#x000a0;on the CT scan,&#x000a0;whereas the glycogen loading of the liver appears&#x000a0;hyperdense on the CT scan. The bright liver on computed tomography can be used as a clue to the diagnosis of glycogenic hepatopathy while taking into consideration other causes of&#x000a0;increased hepatic attenuation like hemochromatosis.<xref ref-type="bibr" rid="article-91155.r23">[23]</xref>&#x000a0;Magnetic resonance imaging (MRI) can also help in establishing the diagnosis of glycogenic hepatopathy.</p>
      </sec>
      <sec id="article-91155.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Glycogenic hepatopathy (GH) is a benign and potentially reversible condition within 2-14 weeks. Improved glycemic control is the key to successful management; with good glycemic control, both clinical and biochemical features of glycogenic hepatopathy can resolve within days to weeks.<xref ref-type="bibr" rid="article-91155.r24">[24]</xref>&#x000a0;The exact glycemic control to treat glycogenic hepatopathy is not yet established but aggressive insulin treatment is not necessary. Parmar et al published a case report in which just 0.6% improvement in HbA1c led to the relief of abdominal pain and a decrease in liver enzymes.<xref ref-type="bibr" rid="article-91155.r25">[25]</xref></p>
      </sec>
      <sec id="article-91155.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other diseases that can cause elevated transaminases with hepatomegaly in patients with diabetes mellitus include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Non-alcoholic fatty liver disease (NAFLD)</p>
          </list-item>
          <list-item>
            <p>Autoimmune hepatitis</p>
          </list-item>
          <list-item>
            <p>Celiac disease</p>
          </list-item>
          <list-item>
            <p>Viral hepatitis</p>
          </list-item>
          <list-item>
            <p>Hemochromatosis</p>
          </list-item>
          <list-item>
            <p>Wilson disease</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-91155.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Glycogenic hepatopathy (GH) is a benign and potentially reversible condition within few days to weeks with good glycemic control. GH has a very good prognosis and it must be carefully differentiated from non-alcoholic fatty liver disease (NAFLD) because NAFLD can progress to fibrosis while GH does not.</p>
      </sec>
      <sec id="article-91155.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Glycogenic hepatopathy itself is a hepatic complication of uncontrolled diabetes mellitus and it is benign and self-limiting with good glycemic control. It does not have any grave complications.</p>
      </sec>
      <sec id="article-91155.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Good control of blood sugar in patients with diabetes can reverse the clinical and biochemical features of glycogenic hepatopathy. Hence dietary modifications to achieve good glycemic control and daily exercise are recommended for all diabetic patients.</p>
      </sec>
      <sec id="article-91155.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Glycogenic hepatopathy should be one of the differential diagnoses in uncontrolled diabetes patients who present with elevated liver enzymes and hepatomegaly.</p>
        <p>Glycogenic hepatopathy must be differentiated from NAFLD as prognosis differs.</p>
        <p>Glycogenic hepatopathy is a benign condition and good glycemic control will reverse the changes.</p>
      </sec>
      <sec id="article-91155.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Early diagnosis and appropriate treatment of glycogenic hepatopathy will lead to a very favorable prognosis. Having a low threshold for the differential diagnosis and coordinating care between the provider, gastroenterologist, and pathologist will improve patient outcomes.</p>
      </sec>
      <sec id="article-91155.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=91155&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=91155">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/glycogenic-hepatopathy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=91155">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/91155/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=91155">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-91155.s17">
        <title>References</title>
        <ref id="article-91155.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruschhaupt</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Rennert</surname>
                <given-names>OM</given-names>
              </name>
            </person-group>
            <article-title>Recurrent hepatomegaly and transient alteration of liver functions in an adolescent with diabetic acidosis.</article-title>
            <source>Clin Pediatr (Phila)</source>
            <year>1970</year>
            <month>Feb</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-4</page-range>
            <pub-id pub-id-type="pmid">4984319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Umpaichitra</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Unusual glycogenic hepatopathy causing abnormal liver enzymes in a morbidly obese adolescent with well-controlled type 2 diabetes: resolved after A1c was normalized by metformin.</article-title>
            <source>Clin Obes</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>281</fpage>
            <page-range>281-4</page-range>
            <pub-id pub-id-type="pmid">27400632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atmaca</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ucler</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kartal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seven</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Alay</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bayram</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Olmez</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Glycogenic Hepatopathy in Type 1 Diabetes Mellitus.</article-title>
            <source>Case Reports Hepatol</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>236143</fpage>
            <pub-id pub-id-type="pmid">26347835</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fitzpatrick</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cotoi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Quaglia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sakellariou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ford-Adams</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Hadzic</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Hepatopathy of Mauriac syndrome: a retrospective review from a tertiary liver centre.</article-title>
            <source>Arch Dis Child</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>99</volume>
            <issue>4</issue>
            <fpage>354</fpage>
            <page-range>354-7</page-range>
            <pub-id pub-id-type="pmid">24412980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berman</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Hepatic glycogen storage during uncontrolled diabetes mellitus. A case report.</article-title>
            <source>S Afr Med J</source>
            <year>1973</year>
            <month>Feb</month>
            <day>03</day>
            <volume>47</volume>
            <issue>5</issue>
            <fpage>184</fpage>
            <page-range>184-6</page-range>
            <pub-id pub-id-type="pmid">4684248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munns</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>McCrossin</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Thomsett</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Batch</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Hepatic glycogenosis: reversible hepatomegaly in type 1 diabetes.</article-title>
            <source>J Paediatr Child Health</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>5</issue>
            <fpage>449</fpage>
            <page-range>449-52</page-range>
            <pub-id pub-id-type="pmid">11036799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sayuk</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Elwing</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Lisker-Melman</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hepatic glycogenosis: an underrecognized source of abnormal liver function tests?</article-title>
            <source>Dig Dis Sci</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>936</fpage>
            <page-range>936-8</page-range>
            <pub-id pub-id-type="pmid">17342391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abaci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bekem</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Unuvar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ozer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bober</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Arslan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ozturk</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Buyukgebiz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hepatic glycogenosis: a rare cause of hepatomegaly in Type 1 diabetes mellitus.</article-title>
            <source>J Diabetes Complications</source>
            <year>2008</year>
            <season>Sep-Oct</season>
            <volume>22</volume>
            <issue>5</issue>
            <fpage>325</fpage>
            <page-range>325-8</page-range>
            <pub-id pub-id-type="pmid">18413182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsujimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nishiofuku</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoshiji</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matsumura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kuriyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uemura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Okamoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fukui</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Rapid onset of glycogen storage hepatomegaly in a type-2 diabetic patient after a massive dose of long-acting insulin and large doses of glucose.</article-title>
            <source>Intern Med</source>
            <year>2006</year>
            <volume>45</volume>
            <issue>7</issue>
            <fpage>469</fpage>
            <page-range>469-73</page-range>
            <pub-id pub-id-type="pmid">16679704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torbenson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Brunt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cummings</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Gottfried</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jakate</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Yeh</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ferrell</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>4</issue>
            <fpage>508</fpage>
            <page-range>508-13</page-range>
            <pub-id pub-id-type="pmid">16625098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kransdorf</surname>
                <given-names>LN</given-names>
              </name>
              <name>
                <surname>Millstine</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Aqel</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Hepatic glycogen deposition in a patient with anorexia nervosa and persistently abnormal transaminase levels.</article-title>
            <source>Clin Res Hepatol Gastroenterol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>e15</fpage>
            <page-range>e15-8</page-range>
            <pub-id pub-id-type="pmid">26066296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Resnick</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Zador</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fish</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Dumping syndrome, a cause of acquired glycogenic hepatopathy.</article-title>
            <source>Pediatr Dev Pathol</source>
            <year>2011</year>
            <season>Jul-Aug</season>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>318</fpage>
            <page-range>318-21</page-range>
            <pub-id pub-id-type="pmid">21338321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Burda</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hochuli</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hepatic glycogen storage disorders: what have we learned in recent years?</article-title>
            <source>Curr Opin Clin Nutr Metab Care</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>18</volume>
            <issue>4</issue>
            <fpage>415</fpage>
            <page-range>415-21</page-range>
            <pub-id pub-id-type="pmid">26001652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iancu</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Shiloh</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dembo</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Hepatomegaly following short-term high-dose steroid therapy.</article-title>
            <source>J Pediatr Gastroenterol Nutr</source>
            <year>1986</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-6</page-range>
            <pub-id pub-id-type="pmid">3944744</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mukewar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lackore</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Enders</surname>
                <given-names>FT</given-names>
              </name>
              <name>
                <surname>Torbenson</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Kamath</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Kudva</surname>
                <given-names>YC</given-names>
              </name>
            </person-group>
            <article-title>Clinical, Biochemical, and Histopathology Features of Patients With Glycogenic Hepatopathy.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>927</fpage>
            <page-range>927-933</page-range>
            <pub-id pub-id-type="pmid">28043933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Hussaini</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Sulaiman</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Alzahrani</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Alenizi</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of hepatopathy in type 1 diabetic children.</article-title>
            <source>BMC Pediatr</source>
            <year>2012</year>
            <month>Oct</month>
            <day>06</day>
            <volume>12</volume>
            <fpage>160</fpage>
            <pub-id pub-id-type="pmid">23039762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sherigar</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Castro</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Guss</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mohanty</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Glycogenic hepatopathy: A narrative review.</article-title>
            <source>World J Hepatol</source>
            <year>2018</year>
            <month>Feb</month>
            <day>27</day>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>172</fpage>
            <page-range>172-185</page-range>
            <pub-id pub-id-type="pmid">29527255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tomihira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kawasaki</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nakajima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Imamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sata</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kage</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sugie</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nunoi</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Intermittent and recurrent hepatomegaly due to glycogen storage in a patient with type 1 diabetes: genetic analysis of the liver glycogen phosphorylase gene (PYGL).</article-title>
            <source>Diabetes Res Clin Pract</source>
            <year>2004</year>
            <month>Aug</month>
            <volume>65</volume>
            <issue>2</issue>
            <fpage>175</fpage>
            <page-range>175-82</page-range>
            <pub-id pub-id-type="pmid">15223230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chatila</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Hepatomegaly and abnormal liver tests due to glycogenosis in adults with diabetes.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>1996</year>
            <month>Nov</month>
            <volume>75</volume>
            <issue>6</issue>
            <fpage>327</fpage>
            <page-range>327-33</page-range>
            <pub-id pub-id-type="pmid">8982149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aljabri</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Bokhari</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Fageeh</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Alharbi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Abaza</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Glycogen hepatopathy in a 13-year-old male with type 1 diabetes.</article-title>
            <source>Ann Saudi Med</source>
            <year>2011</year>
            <season>Jul-Aug</season>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>424</fpage>
            <page-range>424-7</page-range>
            <pub-id pub-id-type="pmid">21727748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Van Thiel</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Diabetes mellitus and the liver.</article-title>
            <source>Semin Liver Dis</source>
            <year>1985</year>
            <month>Feb</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-28</page-range>
            <pub-id pub-id-type="pmid">3885402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Sasatomi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baron</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Acute and Relapsing Hepatitis Caused by Glycogenic Hepatopathy.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>A23</fpage>
            <page-range>A23-A24</page-range>
            <pub-id pub-id-type="pmid">28189697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sweetser</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kraichely</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>The bright liver of glycogenic hepatopathy.</article-title>
            <source>Hepatology</source>
            <year>2010</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>711</fpage>
            <page-range>711-2</page-range>
            <pub-id pub-id-type="pmid">19957373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al Sarkhy</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Zaidi</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Babiker</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Glycogenic hepatopathy, an underdiagnosed cause of relapsing hepatitis in uncontrolled type 1 diabetes mellitus.</article-title>
            <source>Saudi Med J</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>38</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-92</page-range>
            <pub-id pub-id-type="pmid">28042636</pub-id>
          </element-citation>
        </ref>
        <ref id="article-91155.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parmar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Atiq</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Smyrk</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Glycogenic Hepatopathy: Thinking Outside the Box.</article-title>
            <source>Case Rep Gastroenterol</source>
            <year>2015</year>
            <season>May-Aug</season>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>221</fpage>
            <page-range>221-6</page-range>
            <pub-id pub-id-type="pmid">26269698</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
